key: cord-0740816-0j0vpoc0
authors: Li, Anthony; Maier, Allison; Carter, Megan; Guan, Tianxiu Hugh
title: Omicron and S‐gene target failure cases in the highest COVID‐19 case rate region in Canada—December 2021
date: 2022-01-12
journal: J Med Virol
DOI: 10.1002/jmv.27562
sha: 51e7076f4bfc3fe8d935d38a202bd99283c75171
doc_id: 740816
cord_uid: 0j0vpoc0

The SARS-CoV-2 B.1.1.529 variant (Omicron) was classified as a variant of concern by the World Health Organization on November 26, 2021 and first detected in the Kingston, Frontenac, Lennox & Addington (KFL&A) region on December 3, 2021. As it rapidly spreads worldwide, the KFL&A region has had record-setting COVID-19 case numbers, with 1574 active cases as of December 21, 2021 - a higher case rate than any other region in Canada. Of all confirmed or suspect Omicron cases, 59% were 18-24 years old and 27% were 25-39 years old, corresponding with the main outbreak environments being in post-secondary education (N=64) and food & beverage settings (N=106). There have been no hospitalizations, and initial modelling estimates have placed the Re for Omicron in KFL&A at 1.5. The most common symptoms reported were nasal congestion (73%), cough (65%), headaches (54%), sore throat (48%), chills (34%), and fever (32%), while 9.6% of cases were asymptomatic. Of note, only 10% reported shortness of breath. Outside of 45 individuals not yet old enough to be double-vaccinated, 31 cases were unvaccinated, 19 cases were partially vaccinated, and 64 cases had unknown vaccination status. The remainder of cases were at least double-vaccinated. There have been 12 confirmed re-infections with Omicron; all were symptomatic and double-vaccinated. Given the rapid propagation of the Omicron variant as well as the incidence of immune escape in double-vaccinated individuals, public official and citizens must continue to remain cautious and vigilant and ensure a collaborative approach to mitigating community spread. This article is protected by copyright. All rights reserved.

Omicron and S-gene target failure cases in the highest COVID-19 case rate region in Canada-December 2021 In confirmed and suspect Omicron cases, 9.6% were asymptomatic. For symptomatic cases, the most common symptoms reported were nasal congestion (73%), cough (65%), headaches (54%), sore throat (48%). Of note, only 10% reported shortness of breath. 

World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. World Health Organization

PCR performance in the SARS-CoV-2 Omicron variant of concern

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic